Partners & Sponsors
IPM has partnered with a variety of institutions to advance the dapivirine ring from concept to late-stage clinical trials in just seven years, each bringing complementary resources and scientific ingenuity to the ring licensure program:
Microbicide Trials Network (MTN): Funded by the US National Institutes of Health, MTN is a worldwide collaborative clinical trials network focused on preventing the sexual transmission of HIV. Given the dapivirine ring’s promise as a microbicide, MTN has partnered with IPM to advance the dapivirine ring licensure program and conduct the ASPIRE study. MTN will provide a list of its research centre sites when the study launches later this year.
Research center partners: IPM partners with local research centers in Africa to conduct clinical studies. The following research centers are now participating in The Ring Study:
- Madibeng Centre for Research, Brits, North-West, South Africa
- Qhakaza Mbokodo, Ladysmith, KwaZulu-Natal, South Africa
- Maternal, Adolescent and Child Health, (MatCH), Edendale, KwaZulu-Natal, South Africa
- Prevention of HIV/AIDS Project (PHIVA), Pinetown, KwaZulu-Natal, South Africa
- Desmond Tutu HIV Foundation, Masiphumelele, South Africa
- Ndlovu Medical Centre, Limpopo, South Africa
- MRC/UVRI Uganda Research Unit on AIDS, Masaka, Uganda
Janssen R&D Ireland: IPM is developing dapivirine for use as a microbicide through a royalty-free licensing agreement with Janssen R&D Ireland (previously Tibotec Pharmaceutials), one of the Janssen pharmaceutical companies of Johnson & Johnson.
QPharma: A Sweden-based contract developer and pharmaceuticals manufacturer with 35 years experience, QPharma is manufacturing the dapivirine vaginal rings for the licensure program using highly specialized equipment.
Donors: IPM’s work to date has been supported by governments, foundations, and multilateral organizations including: Belgium, Canada, Denmark, France, Germany, Ireland, Netherlands, Norway, Spain, Sweden, the United Kingdom and the United States; the European Commission, the World Bank, UNFPA, the Bill & Melinda Gates Foundation, the Rockefeller Foundation, the OPEC Fund for International Development, and the MAC AIDS Fund. View IPM’s donor list.